Montreal Gazette - Montreal AIDS researcher honoured

Pioneering AIDS researcher Mark Wainberg has been elected a Fellow of the prestigious American Association for the Advancement of Science “for distinguished contributions to HIV drug development,” among other achievements.

Wainberg, director of the McGill AIDS Centre, has been credited for his 1989 work with BioChem Pharma in the identification of 3TC as an anti-viral drug. The AAAS also lauded the 66-year-old Wainberg for “striving to make HIV drug access a reality for all.”